| Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease CN França, MCO Izar, MNS Hortêncio, JB do Amaral, CES Ferreira, ... Clinical science 131 (12), 1215-1224, 2017 | 163 | 2017 |
| Diabetic fibrosis I Tuleta, NG Frangogiannis Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1867 (4), 166044, 2021 | 94 | 2021 |
| Cells of primarily extravalvular origin in degenerative aortic valves and bioprostheses D Skowasch, S Schrempf, N Wernert, M Steinmetz, A Jabs, I Tuleta, ... European heart journal 26 (23), 2576-2580, 2005 | 72 | 2005 |
| Clinical outcomes and response to vericiguat according to index heart failure event: insights from the VICTORIA trial CSP Lam, A Giczewska, K Sliwa, F Edelmann, J Refsgaard, E Bocchi, ... Jama Cardiology 6 (6), 706-712, 2021 | 61 | 2021 |
| Truncated titin proteins and titin haploinsufficiency are targets for functional recovery in human cardiomyopathy due to TTN mutations A Fomin, A Gärtner, L Cyganek, M Tiburcy, I Tuleta, L Wellers, L Folsche, ... Science translational medicine 13 (618), eabd3079, 2021 | 59 | 2021 |
| Anti-inflammatory effects of 1, 8-cineole (eucalyptol) improve glucocorticoid effects in vitro: a novel approach of steroid-sparing add-on therapy for COPD and asthma? LJ Juergens, K Racké, I Tuleta, M Stoeber, UR Juergens Synergy 5, 1-8, 2017 | 52 | 2017 |
| Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities I Tuleta, NG Frangogiannis Advanced drug delivery reviews 176, 113904, 2021 | 51 | 2021 |
| Asthma is associated with atherosclerotic artery changes I Tuleta, D Skowasch, F Aurich, N Eckstein, R Schueler, C Pizarro, ... PLoS One 12 (10), e0186820, 2017 | 48 | 2017 |
| An international multicenter evaluation of type 5 long QT syndrome: a low penetrant primary arrhythmic condition JD Roberts, SY Asaki, A Mazzanti, JM Bos, I Tuleta, AR Muir, L Crotti, ... Circulation 141 (6), 429-439, 2020 | 45 | 2020 |
| Hypoxia-induced endothelial dysfunction in apolipoprotein E-deficient mice; effects of infliximab and L-glutathione I Tuleta, CN França, D Wenzel, B Fleischmann, G Nickenig, N Werner, ... Atherosclerosis 236 (2), 400-410, 2014 | 45 | 2014 |
| Intermittent hypoxia impairs endothelial function in early preatherosclerosis I Tuleta, CN França, D Wenzel, B Fleischmann, G Nickenig, N Werner, ... Pulmonary Function, 1-7, 2015 | 44 | 2015 |
| Intermittent hypoxia contributes to the lung damage by increased oxidative stress, inflammation, and disbalance in protease/antiprotease system I Tuleta, F Stöckigt, UR Juergens, C Pizarro, JW Schrickel, G Kristiansen, ... Lung 194, 1015-1020, 2016 | 43 | 2016 |
| Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy P Velling, D Skowasch, S Pabst, E Jansen, I Tuleta, C Grohé European journal of medical research 16 (9), 407-410, 2011 | 37 | 2011 |
| Antiplatelet effects of antidepressant treatment: a randomized comparison between escitalopram and nortriptyline A Flöck, A Zobel, G Bauriedel, I Tuleta, C Hammerstingl, S Höfels, ... Thrombosis Research 126 (2), e83-e87, 2010 | 34 | 2010 |
| Toll-like receptor 2 gene polymorphisms Arg677Trp and Arg753Gln in chronic obstructive pulmonary disease S Pabst, V Yenice, M Lennarz, I Tuleta, G Nickenig, A Gillissen, C Grohé Lung 187, 173-178, 2009 | 34 | 2009 |
| Underdiagnosis of obstructive sleep apnoea in peripheral arterial disease C Pizarro, C Schaefer, I Kimeu, S Pingel, F Horlbeck, I Tuleta, G Nickenig, ... Respiration 89 (3), 214-220, 2015 | 31 | 2015 |
| High prevalence of COPD in atherosclerosis patients I Tuleta, T Farrag, L Busse, C Pizarro, C Schaefer, S Pingel, G Nickenig, ... International journal of chronic obstructive pulmonary disease, 3047-3053, 2017 | 29 | 2017 |
| Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease S Pabst, B Theis, A Gillissen, M Lennarz, I Tuleta, G Nickenig, ... European Journal of Medical Research 14 (4), 1-5, 2009 | 29 | 2009 |
| Effect of endobronchial valve therapy on pulmonary perfusion and ventilation distribution C Pizarro, H Ahmadzadehfar, M Essler, I Tuleta, R Fimmers, G Nickenig, ... PloS one 10 (3), e0118976, 2015 | 27 | 2015 |
| Risk and fate of residual interatrial shunting after transcatheter closure of patent foramen ovale: a long term follow up study C Hammerstingl, G Bauriedel, C Stüsser, D Momcilovic, I Tuleta, ... European journal of medical research 16, 13-19, 2011 | 27 | 2011 |
